Pascual Sánchez‐Juan

Universidad de Cantabria — Spain

Medicine · Health Sciences

49h-index15.6kcitations279works3.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(93), Dementia and Cognitive Impairment Research(59), Parkinson's Disease Mechanisms and Treatments(29), Prion Diseases and Protein Misfolding(29), Neurological diseases and metabolism(27)

Publications252 total

Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer’s disease
Molecular Neurodegeneration·2025· 1 citedOpen Access
Associations of lifestyle factors with amyloid pathology in persons without dementia
Journal of Alzheimer s Disease·2025Open Access
Psychometric Properties of the 7-Item Sense of Competence Questionnaire: Assessing Informal Caregivers’ Self-Perceived Competence in Mild Cognitive Impairment
Neurology and Therapy·2025Open Access
Amyloid‐negative neuropsychological norms: Added value in the era of biomarkers and disease‐modifying therapies
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2025Open Access
Morphological variations and cortical atrophy of the precuneus in normal aging and Alzheimer's disease
Journal of Anatomy·2025· 2 citedOpen Access
Early microglial and astrocyte reactivity in preclinical Alzheimer's disease
Alzheimer s & Dementia·2025· 9 citedOpen Access
Blood-based biomarkers for Alzheimer's disease: positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology
Neurología (English Edition)·2025· 1 citedOpen Access
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias
2025Open Access
Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis
Journal of the Neurological Sciences·2025· 3 cited
Diagnostic performance of plasma p-tau217 in a memory clinic cohort using the Lumipulse automated platform
Alzheimer s Research & Therapy·2025· 7 citedOpen Access
The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients
Brain·2025· 7 citedOpen Access
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
Nature Communications·2025· 11 citedOpen Access
Depressive Symptoms and Amyloid Pathology
JAMA Psychiatry·2025· 17 citedOpen Access
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study
JAMA Network Open·2025· 4 citedOpen Access
Speech Biomarkers Predict Amyloid Status in Cognitively Unimpaired Adults
SSRN Electronic Journal·2025Open Access
Speech biomarkers predict amyloid status in cognitively unimpaired adults
Intelligence-Based Medicine·2025Open Access
Longitudinal trajectory of plasma p-tau217 in cognitively unimpaired subjects
Alzheimer s Research & Therapy·2024· 5 citedOpen Access
Cholinergic white matter pathways in Alzheimer’s disease, dementia with Lewy bodies, and other neurodegenerative diseases: a post‐mortem MRI study
Alzheimer s & Dementia·2024Open Access
Plasma biomarkers in a cohort of cases with dementia and in cognitively preserved nonagenarians
Alzheimer s & Dementia·2024Open Access
KLOTHO‐VS heterozygosity ameliorates the effects of APOE ε4 on longitudinal hippocampal atrophy
Alzheimer s & Dementia·2024Open Access
page 1 of 13Next →

Frequent Co-authors

Eloy Rodríguez‐Rodríguez(19), Alberto Lleó(14), Onofre Combarros(14), Cornelia M. van Duijn(12), Juan Fortea(12), Jordi Clarimón(12), José Berciano(11), Inga Zerr(10), Daniel Alcolea(10), Ana Pozueta(10), Jon Infante(10), Pau Pástor(8), Miguel Calero(8), Richard Knight(8), Raquel Sánchez‐Valle(8), Carmen Lage(8), Agustı́n Ruiz(7), Anna Ladogana(7), Wiesje M. van der Flier(7), Rafael Blesa(7)